Member Info for Mulder

Brutal sell off into the close leaves this back at 1 year lows.

Drax Group generates �1.7bn for economy http://www.yorkshirepost.co.uk/news/drax-group-generates-1-7bn-for-economy-1-8810978 Power generation giant Drax Group contributed �1.7bn to the British economy last year, helping to support thousands of jobs around the country, research has shown. The power company based near Selby generated �419 million in the Yorkshire and Humber region alone, supporting 3,650 jobs. Researchers at Oxford Economics showed that the power station, whose chairwoman is Dorothy Thompson, which employs around 900 people and has seen three of its six generating units converted in recent years to use compressed wood pellets, generated 16 per cent of the country�s renewable electricity in 2016 � enough for four million households, the equivalent of Leeds, Manchester, Sheffield and Liverpool.

Hard to believe this hit 2300p as recently as March. The market can be brutal. The balance sheet remains strong however with an equity ratio >2 . P/E around 15 is also not high compared to historical average >20. Trading not far off its NAV/book price either. GSK trades at 15x book price. Possibility of M&A/private buy out remains.

That tells me he fully expects a better offer probably around 330p otherwise he would not be buying more at 300p.

Must be almost bursting now - fair price for Shire in M&A scenario? FT, AUGUST 2017 Impatient Shire boss waits for market to catch up Shares hardly move despite pharma group�s advances Flemming Ornskov, the hard-driving Dane who heads Shire, moves too fast to be a marathon runner. And he is much too impatient to make a good angler. Last year he bought Baxalta, the US specialist in drugs for rare diseases for $32bn � a deal that more than doubled Shire�s revenues to $11bn-plus but also lifted debt to $22bn, or 4.6 times earnings before nasties. ***Last month, barely a year after inking the deal, Mr Ornskov said integration was GOING SWIMMINGLY and admitted he was FED UP with how long the market was taking to appreciate it. Shire�s shares have fallen nearly 15 per cent since January. On Thursday, the group again said it was taking out costs quicker than expected and debt was coming down fast. **Soon borrowings will be BELOW THREE TIMES pre-nasties. But in the same breath, Mr Ornskov has announced he might sell or float Shire�s neuroscience arm which could fetch up to $15BN and bring down debt.**

Trading at 3 year lows. Very low P/E of 10.8 Yield approaching 5% and covered 2x by earnings. Sorrell may sell the company also and if he does we're looking at around 1800p http://www.mmm-online.com/agencies/bank-publicis-and-wpp-are-takeover-targets-and-accenture-is-a-credible-buyer/article/696301/ Accenture is a credible buyer," he said. "In view of its size ($90.4bn/�67.5bn) market capitalisation), it could acquire and easily integrate Publicis (�13.3bn/�11.7bn) or WPP (�17.5bn). WPP is down more than 33% this year

A very very delayed reaction by the market if it has taken them 18 months to not like the debt levels because they certainly have not got any worse in that time. Total BS once again by Mr Market.

EPS up strongly. Now trading on a P/E of just 13. Yielding around 3% and almost 3x covered by earnings. Solid balance sheet with equity ratio >2 China growth potential Should really be trading at least 15x earnings ~ 4200p

ADD rating.

Woodford will want to recoup some of his losses from AA and Provident. Holds 15% stake. Will demand a better offer.

360p paid for 30% stake 2 years ago. Match or better that as nothing has changed. Balance sheet same/better.

Not selling around 300p. Offer will be increased IMO or Hospital Corporation America could step in also with rival bid. This was hitting close to 400p only in the Summer.

Agree. Significantly undervalues Spire. Will have to increase to around 350p

The 10% rise and all that buying you refer to was clearly the result of a leak. Sad but true. Happens all the time.

Even if the board rejects the offer this should open above 320p tomorrow.

Mediclinic bought their 30% stake at 360p so I reckon they will have to bump up their offer to this level.

Explains why directors were not buying. Surprised Ash was allowed to buy as technically must have been in a closed period? Wonder what he makes of it? The 220p lockdown for weeks looks increasingly dodgy now doesn't it? Alas this is the market...

The Times is reporting a £1.3Bn bid which actually comes close to 325p which is cheap IMO when you consider this was up at 400p last year. Offer will be revised up to 340-350p IMO but we should open around 325p tomorrow. Board will probably reject this first offer.

What did I say? Well done to those who held. Mediclinic it is then.

Zwane is rightly being attacked for the charter. Looks like sense has prevailed. Markets will fall soon then rise for the annual fixed Santa rally!